Funding round

Biolevate raises €30M Series A round

Biolevate (France) has raised €30M in a Series A round, announced on September 22, 2026. The company is Automates scientific and regulatory workflows for life sciences organizations. The round was led by RAISE France, with participation from Orange Ventures, MSD Global Health Innovation Fund (MGHIF), Station F, EQT Ventures.

Biolevate raised €30 million in Series A funding to expand its workflow automation platform, strengthen products and support international growth.

Company

Biolevate

Amount

€30M (~$34.4M)

Round

Series A

Sector

Life sciences AI

Country

France

Announced

September 22, 2026

Track every raise, every day

This deal appeared in The Daily Raise, September 22, 2026. Get the next edition in your inbox.

Just raised too?

Turn your funding news into guaranteed media coverage while the momentum lasts.

Get featured